ABT logo

Abbott Laboratories (ABT) Cash from operations

annual CFO:

$8.56B+$1.30B(+17.86%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ABT annual cash flow from operations is $8.56 billion, with the most recent change of +$1.30 billion (+17.86%) on December 31, 2024.
  • During the last 3 years, ABT annual CFO has fallen by -$1.98 billion (-18.75%).
  • ABT annual CFO is now -18.75% below its all-time high of $10.53 billion, reached on December 31, 2021.

Performance

ABT Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

quarterly CFO:

$1.42B-$1.45B(-50.59%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ABT quarterly cash flow from operations is $1.42 billion, with the most recent change of -$1.45 billion (-50.59%) on March 1, 2025.
  • Over the past year, ABT quarterly CFO has increased by +$392.00 million (+38.24%).
  • ABT quarterly CFO is now -62.69% below its all-time high of $3.80 billion, reached on December 31, 2020.

Performance

ABT quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

TTM CFO:

$8.95B+$392.00M(+4.58%)
March 1, 2025

Summary

  • As of today (May 29, 2025), ABT TTM cash flow from operations is $8.95 billion, with the most recent change of +$392.00 million (+4.58%) on March 1, 2025.
  • Over the past year, ABT TTM CFO has increased by +$1.81 billion (+25.30%).
  • ABT TTM CFO is now -20.54% below its all-time high of $11.26 billion, reached on September 30, 2021.

Performance

ABT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ABT Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.9%+38.2%+25.3%
3 y3 years-18.8%-31.4%-10.2%
5 y5 years+39.5%+98.2%+45.8%

ABT Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.8%+17.9%-53.4%+38.2%-13.3%+36.7%
5 y5-year-18.8%+39.5%-62.7%+98.2%-20.5%+45.8%
alltimeall time-18.8%+791.5%-62.7%+1623.7%-20.5%+4014.9%

ABT Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.42B(-50.6%)
$8.95B(+4.6%)
Dec 2024
$8.56B(+17.9%)
$2.87B(+6.0%)
$8.56B(-1.9%)
Sep 2024
-
$2.71B(+38.0%)
$8.73B(+10.5%)
Jun 2024
-
$1.96B(+91.2%)
$7.90B(+10.6%)
Mar 2024
-
$1.02B(-66.3%)
$7.14B(-1.6%)
Dec 2023
$7.26B(-24.2%)
$3.04B(+61.9%)
$7.26B(+10.9%)
Sep 2023
-
$1.88B(+56.0%)
$6.55B(-12.1%)
Jun 2023
-
$1.20B(+5.2%)
$7.45B(-13.9%)
Mar 2023
-
$1.14B(-50.9%)
$8.66B(-9.6%)
Dec 2022
$9.58B(-9.0%)
$2.33B(-16.3%)
$9.58B(-7.2%)
Sep 2022
-
$2.78B(+15.4%)
$10.32B(+0.8%)
Jun 2022
-
$2.41B(+16.7%)
$10.24B(+2.8%)
Mar 2022
-
$2.06B(-32.7%)
$9.96B(-5.4%)
Dec 2021
$10.53B(+33.3%)
$3.07B(+13.6%)
$10.53B(-6.5%)
Sep 2021
-
$2.70B(+26.9%)
$11.26B(+6.0%)
Jun 2021
-
$2.13B(-19.3%)
$10.63B(+8.2%)
Mar 2021
-
$2.64B(-30.6%)
$9.82B(+24.3%)
Dec 2020
$7.90B(+28.8%)
$3.80B(+83.8%)
$7.90B(+21.2%)
Sep 2020
-
$2.07B(+56.3%)
$6.52B(+1.8%)
Jun 2020
-
$1.32B(+84.9%)
$6.40B(+4.3%)
Mar 2020
-
$715.00M(-70.4%)
$6.14B(+0.0%)
Dec 2019
$6.14B(-2.6%)
$2.42B(+24.0%)
$6.14B(+11.9%)
Sep 2019
-
$1.95B(+83.8%)
$5.49B(-4.1%)
Jun 2019
-
$1.06B(+48.9%)
$5.72B(-3.1%)
Mar 2019
-
$712.00M(-59.7%)
$5.90B(-6.3%)
Dec 2018
$6.30B(+13.1%)
$1.76B(-19.1%)
$6.30B(+2.0%)
Sep 2018
-
$2.18B(+75.5%)
$6.17B(+3.0%)
Jun 2018
-
$1.24B(+12.3%)
$6.00B(-1.8%)
Mar 2018
-
$1.11B(-32.4%)
$6.10B(+9.6%)
Dec 2017
$5.57B(+73.9%)
$1.64B(-18.2%)
$5.57B(+9.2%)
Sep 2017
-
$2.00B(+48.4%)
$5.10B(+18.3%)
Jun 2017
-
$1.35B(+135.4%)
$4.31B(+11.4%)
Mar 2017
-
$574.00M(-50.9%)
$3.87B(+20.8%)
Dec 2016
$3.20B(+8.0%)
$1.17B(-3.9%)
$3.20B(+12.0%)
Sep 2016
-
$1.22B(+33.9%)
$2.86B(+0.8%)
Jun 2016
-
$909.00M(-1077.4%)
$2.84B(-1.1%)
Mar 2016
-
-$93.00M(-111.2%)
$2.87B(-3.2%)
Dec 2015
$2.97B(-19.3%)
$828.00M(-30.7%)
$2.97B(-12.1%)
Sep 2015
-
$1.20B(+27.0%)
$3.38B(-0.2%)
Jun 2015
-
$941.00M(>+9900.0%)
$3.38B(+1.2%)
Mar 2015
-
$2.00M(-99.8%)
$3.34B(-9.1%)
Dec 2014
$3.67B(+10.6%)
$1.24B(+3.1%)
$3.67B(-9.5%)
Sep 2014
-
$1.20B(+33.4%)
$4.06B(+20.1%)
Jun 2014
-
$900.00M(+167.9%)
$3.38B(+5.7%)
Mar 2014
-
$336.00M(-79.3%)
$3.20B(-3.7%)
Dec 2013
$3.32B(-64.3%)
$1.63B(+211.3%)
$3.32B(+3.8%)
Sep 2013
-
$522.00M(-27.2%)
$3.20B(-48.4%)
Jun 2013
-
$717.00M(+55.9%)
$6.20B(-17.9%)
Mar 2013
-
$460.00M(-69.4%)
$7.55B(-18.9%)
Dec 2012
$9.31B(+3.8%)
$1.50B(-57.3%)
$9.31B(+1.1%)
Sep 2012
-
$3.52B(+70.3%)
$9.21B(+5.3%)
Jun 2012
-
$2.07B(-7.1%)
$8.75B(-4.8%)
Mar 2012
-
$2.22B(+58.8%)
$9.18B(+2.4%)
Dec 2011
$8.97B(+2.7%)
$1.40B(-54.1%)
$8.97B(-9.3%)
Sep 2011
-
$3.05B(+22.0%)
$9.89B(+5.4%)
Jun 2011
-
$2.50B(+24.5%)
$9.38B(+1.7%)
Mar 2011
-
$2.01B(-13.2%)
$9.22B(+5.6%)
Dec 2010
$8.74B(+20.1%)
$2.32B(-9.1%)
$8.74B(+5.9%)
Sep 2010
-
$2.55B(+8.5%)
$8.25B(-5.5%)
Jun 2010
-
$2.35B(+54.2%)
$8.73B(+7.8%)
Mar 2010
-
$1.52B(-16.9%)
$8.10B(+11.3%)
Dec 2009
$7.28B(+4.0%)
$1.83B(-39.5%)
$7.28B(+9.0%)
Sep 2009
-
$3.03B(+76.8%)
$6.68B(+5.2%)
Jun 2009
-
$1.71B(+145.3%)
$6.34B(-0.7%)
Mar 2009
-
$698.72M(-43.3%)
$6.39B(-8.7%)
Dec 2008
$6.99B(+34.9%)
$1.23B(-54.3%)
$6.99B(+2.7%)
Sep 2008
-
$2.70B(+53.5%)
$6.81B(+20.5%)
Jun 2008
-
$1.76B(+34.7%)
$5.65B(+4.0%)
Mar 2008
-
$1.31B(+24.3%)
$5.43B(+4.8%)
Dec 2007
$5.18B
$1.05B(-31.7%)
$5.18B(-4.4%)
Sep 2007
-
$1.54B(-0.1%)
$5.42B(+4.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
$1.54B(+45.7%)
$5.17B(-0.6%)
Mar 2007
-
$1.06B(-18.0%)
$5.20B(-2.4%)
Dec 2006
$5.33B(+3.0%)
$1.29B(+0.3%)
$5.33B(-1.2%)
Sep 2006
-
$1.28B(-18.3%)
$5.39B(-2.5%)
Jun 2006
-
$1.57B(+32.9%)
$5.53B(-5.0%)
Mar 2006
-
$1.18B(-12.4%)
$5.82B(+12.6%)
Dec 2005
$5.17B(+15.8%)
$1.35B(-5.2%)
$5.17B(+10.4%)
Sep 2005
-
$1.42B(-23.6%)
$4.68B(+13.6%)
Jun 2005
-
$1.86B(+249.3%)
$4.13B(+11.4%)
Mar 2005
-
$533.73M(-38.1%)
$3.70B(-17.1%)
Dec 2004
$4.47B(+25.7%)
$861.69M(-0.5%)
$4.47B(+6.8%)
Sep 2004
-
$865.78M(-40.0%)
$4.18B(-3.9%)
Jun 2004
-
$1.44B(+11.3%)
$4.35B(+11.5%)
Mar 2004
-
$1.30B(+123.9%)
$3.91B(+9.9%)
Dec 2003
$3.55B(-11.0%)
$578.97M(-44.1%)
$3.55B(-10.8%)
Sep 2003
-
$1.04B(+4.0%)
$3.98B(+3.5%)
Jun 2003
-
$995.61M(+5.6%)
$3.85B(+2.0%)
Mar 2003
-
$943.02M(-6.5%)
$3.77B(-5.5%)
Dec 2002
$3.99B(+11.9%)
$1.01B(+12.0%)
$3.99B(+3.1%)
Sep 2002
-
$900.93M(-2.0%)
$3.87B(-6.8%)
Jun 2002
-
$918.87M(-21.0%)
$4.15B(+9.0%)
Mar 2002
-
$1.16B(+31.1%)
$3.81B(+6.9%)
Dec 2001
$3.57B(+15.1%)
$887.39M(-25.1%)
$3.57B(+3.3%)
Sep 2001
-
$1.18B(+105.4%)
$3.45B(+17.2%)
Jun 2001
-
$576.51M(-37.2%)
$2.95B(-19.0%)
Mar 2001
-
$918.57M(+18.6%)
$3.64B(+17.4%)
Dec 2000
$3.10B(+5.5%)
$774.18M(+14.2%)
$3.10B(+16.8%)
Sep 2000
-
$677.88M(-46.5%)
$2.65B(-10.7%)
Jun 2000
-
$1.27B(+233.6%)
$2.97B(+19.0%)
Mar 2000
-
$379.96M(+15.7%)
$2.50B(-15.0%)
Dec 1999
$2.94B(+5.7%)
$328.46M(-67.0%)
$2.94B(-5.9%)
Sep 1999
-
$995.94M(+25.6%)
$3.12B(+15.8%)
Jun 1999
-
$792.96M(-3.3%)
$2.70B(-0.9%)
Mar 1999
-
$820.14M(+60.2%)
$2.72B(-2.2%)
Dec 1998
$2.78B(+4.5%)
$512.10M(-10.2%)
$2.78B(-4.7%)
Sep 1998
-
$570.46M(-30.1%)
$2.92B(-2.5%)
Jun 1998
-
$816.24M(-7.4%)
$2.99B(+8.6%)
Mar 1998
-
$881.40M(+35.6%)
$2.76B(+3.6%)
Dec 1997
$2.66B(+11.7%)
$649.90M(+0.6%)
$2.66B(+3.1%)
Sep 1997
-
$646.29M(+11.6%)
$2.58B(+0.5%)
Jun 1997
-
$579.28M(-26.2%)
$2.57B(+3.4%)
Mar 1997
-
$784.63M(+37.5%)
$2.48B(+4.2%)
Dec 1996
$2.38B(+21.2%)
$570.56M(-9.8%)
$2.38B(+7.2%)
Sep 1996
-
$632.54M(+27.8%)
$2.22B(+5.4%)
Jun 1996
-
$494.80M(-27.7%)
$2.11B(-1.5%)
Mar 1996
-
$684.20M(+66.4%)
$2.14B(+8.9%)
Dec 1995
$1.97B(-11.1%)
$411.18M(-20.8%)
$1.97B(-8.4%)
Sep 1995
-
$519.18M(-1.5%)
$2.15B(-3.6%)
Jun 1995
-
$526.89M(+3.7%)
$2.23B(+2.5%)
Mar 1995
-
$508.33M(-14.1%)
$2.17B(-1.7%)
Dec 1994
$2.21B(+19.8%)
$591.69M(-1.5%)
$2.21B(+5.7%)
Sep 1994
-
$600.46M(+26.9%)
$2.09B(+1.3%)
Jun 1994
-
$473.14M(-13.5%)
$2.06B(+5.5%)
Mar 1994
-
$546.85M(+15.8%)
$1.96B(+6.0%)
Dec 1993
$1.85B(+33.0%)
$472.11M(-17.6%)
$1.85B(-1.9%)
Sep 1993
-
$572.70M(+56.4%)
$1.88B(+19.3%)
Jun 1993
-
$366.10M(-16.0%)
$1.58B(+1.4%)
Mar 1993
-
$436.00M(-14.2%)
$1.56B(+12.1%)
Dec 1992
$1.39B(-4.4%)
$508.40M(+90.1%)
$1.39B(+7.3%)
Sep 1992
-
$267.50M(-22.4%)
$1.29B(-9.8%)
Jun 1992
-
$344.60M(+28.4%)
$1.44B(-2.8%)
Mar 1992
-
$268.30M(-35.2%)
$1.48B(+1.6%)
Dec 1991
$1.45B(+21.0%)
$414.20M(+1.4%)
$1.45B(+2.8%)
Sep 1991
-
$408.30M(+6.0%)
$1.41B(+3.5%)
Jun 1991
-
$385.30M(+57.0%)
$1.37B(+11.2%)
Mar 1991
-
$245.40M(-34.5%)
$1.23B(+2.3%)
Dec 1990
$1.20B(+25.1%)
$374.90M(+4.0%)
$1.20B(+45.4%)
Sep 1990
-
$360.50M(+45.4%)
$826.00M(+77.4%)
Jun 1990
-
$248.00M(+14.0%)
$465.50M(+114.0%)
Mar 1990
-
$217.50M
$217.50M
Dec 1989
$959.90M
-
-

FAQ

  • What is Abbott Laboratories annual cash flow from operations?
  • What is the all time high annual CFO for Abbott Laboratories?
  • What is Abbott Laboratories annual CFO year-on-year change?
  • What is Abbott Laboratories quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Abbott Laboratories?
  • What is Abbott Laboratories quarterly CFO year-on-year change?
  • What is Abbott Laboratories TTM cash flow from operations?
  • What is the all time high TTM CFO for Abbott Laboratories?
  • What is Abbott Laboratories TTM CFO year-on-year change?

What is Abbott Laboratories annual cash flow from operations?

The current annual CFO of ABT is $8.56B

What is the all time high annual CFO for Abbott Laboratories?

Abbott Laboratories all-time high annual cash flow from operations is $10.53B

What is Abbott Laboratories annual CFO year-on-year change?

Over the past year, ABT annual cash flow from operations has changed by +$1.30B (+17.86%)

What is Abbott Laboratories quarterly cash flow from operations?

The current quarterly CFO of ABT is $1.42B

What is the all time high quarterly CFO for Abbott Laboratories?

Abbott Laboratories all-time high quarterly cash flow from operations is $3.80B

What is Abbott Laboratories quarterly CFO year-on-year change?

Over the past year, ABT quarterly cash flow from operations has changed by +$392.00M (+38.24%)

What is Abbott Laboratories TTM cash flow from operations?

The current TTM CFO of ABT is $8.95B

What is the all time high TTM CFO for Abbott Laboratories?

Abbott Laboratories all-time high TTM cash flow from operations is $11.26B

What is Abbott Laboratories TTM CFO year-on-year change?

Over the past year, ABT TTM cash flow from operations has changed by +$1.81B (+25.30%)
On this page